精力药理学 SCIE

期刊简介估计审稿时候： 较快,2-4周

Official Journal of the European Behavioural Pharmacology Society (EBPS)

Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields:

Human Psychopharmacology: Experimental

This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered.

Human Psychopharmacology: Clinical and Translational

This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects.

Preclinical psychopharmacology: Behavioral and Neural

This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels.

Preclinical Psychopharmacology: Translational

This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways.

Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic

This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.

欧洲行动药理学会 (EBPS) 官方期刊

《精力药理学》是一本国际期刊，涵盖说明药物影响行动的机制这一普遍主题。该期刊的规模涵盖以下范畴：

人类精力药理学：尝试

本局部包罗描写药物对人类情感、行动、认知和心理影响的稿件。该期刊鼓动勉励提交触及脑成像、遗传学、神经内排泄学和发育主题的稿件。本局部中的稿件凡是描写在受控前提下停止的研讨，但偶然也会斟酌描写性或察看性研讨。

人类精力药理学：临床和转化

本局部包罗触及药物和精力疾病普遍交加的研讨。这不只包罗临床实验和药物操纵和代谢、药物监测和药物风行病学的研讨，还包罗操纵各类临床相干体例的任务，包罗神经影象学、药物遗传学、认知迷信、生物标记物等。出格鼓动勉励将临床前常识转化为临床常识的任务。提交到本节的首要特色是它们触及临床方面。

临床前精力药理学：行动和神经

本节斟酌具备明白化学布局的化合物对人类之外物种的行动任何方面的影响的报告，出格是与神经化学效应相干时。接待包罗与行动相连系的神经迷信手艺的稿件。咱们鼓动勉励报告在行动和份子程度上深切领会药物感化机制的研讨。

临床前精力药理学：转化

本局部斟酌操纵与疾病相干的临床前模子和测试来加强对可以或许对精力病或精力病患者具备医治代价的焦点机制的决议信念的手稿，或报告可以或许转化为临床的临床前操纵和挑衅的手稿。旨在按照临床发明（反向翻译）改良临床前模子的研讨也将遭到斟酌。该期刊出格鼓动勉励提交整合靶构造裸露丈量、份子靶标活性和/或靶向生化路子调理的投稿。

临床前精力药理学：份子、遗传和表观遗传

本局部重点先容神经药理学药剂/药物的份子和细胞感化，和影响安康和疾病中枢神经系统的药物靶标的辨认/考证。咱们出格鼓动勉励在份子程度上深切领会药物感化机制的研讨。接待包罗遗传或表观遗传对神经化学或行动影响的证据的稿件。

《Psychopharmacology》(精力药理学)编辑部通信体例为SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013。若是您须要辅佐投稿或润稿办事，您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年，熟习颁发政策，可为您供给一对一投稿指点，防止您在投稿时频仍碰鼻，节流您的可贵时候，有用晋升颁发机率，确保SCI检索（检索不了全额退款）。咱们视诺言为生命，多方面确保文章宁静失密，在任何环境下都不会泄漏您的小我信息或稿件内容。